106 related articles for article (PubMed ID: 8453578)
1. CA 125 and CA 19-9 immunolocalization in normal, hyperplastic, and carcinomatous endometrium.
Podczaski E; Kaminski PF; Zaino R
Cancer; 1993 Apr; 71(8):2551-6. PubMed ID: 8453578
[TBL] [Abstract][Full Text] [Related]
2. CD44 expression in normal, hyperplastic, and malignant endometrium.
Saegusa M; Hashimura M; Okayasu I
J Pathol; 1998 Mar; 184(3):297-306. PubMed ID: 9614383
[TBL] [Abstract][Full Text] [Related]
3. Simple mucin-type carbohydrates in normal and malignant human endometrium.
Ravn V; Mandel U; Svenstrup B; Dabelsteen E
Int J Gynecol Pathol; 1995 Apr; 14(2):158-66. PubMed ID: 8601528
[TBL] [Abstract][Full Text] [Related]
4. The expression of Ca antigen in normal, hyperplastic and neoplastic endometrium.
Ferguson AM; Fox H
Br J Obstet Gynaecol; 1984 Oct; 91(10):1042-5. PubMed ID: 6386039
[TBL] [Abstract][Full Text] [Related]
5. p53lyn and p56lyn: a new signaling pathway in human endometrium and endometrial adenocarcinomas.
Couchman GM; Bentley R; Tsao MS; Raszmann K; McLachlan JA; Walmer DK
J Soc Gynecol Investig; 1997; 4(2):103-9. PubMed ID: 9101470
[TBL] [Abstract][Full Text] [Related]
6. CA 19-9, CA 125 and CEA in the endometrial mucosa during the menstrual cycle, in atypical hyperplasia and endometrial carcinoma.
Neunteufel W; Breitenecker G
Cancer Lett; 1989 Nov; 48(1):77-83. PubMed ID: 2684391
[TBL] [Abstract][Full Text] [Related]
7. The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium.
Sonoda K; Kaku T; Hirakawa T; Kobayashi H; Amada S; Sakai K; Nakashima M; Watanabe T; Nakano H
Gynecol Oncol; 2000 Dec; 79(3):424-9. PubMed ID: 11104614
[TBL] [Abstract][Full Text] [Related]
8. Tissue CA 125 and CA 19-9 in malignant, mixed mesodermal tumors of the uterus.
Podczaski E; Kaminski P; Hackett TE; Olt GJ; Zaino R
Gynecol Oncol; 1993 Apr; 49(1):56-60. PubMed ID: 8387061
[TBL] [Abstract][Full Text] [Related]
9. Enhanced CD24 expression in endometrial carcinoma and its expression pattern in normal and hyperplastic endometrium.
Kim KH; Choi JS; Kim JM; Choi YL; Shin YK; Lee HC; Seong IO; Kim BK; Chae SW; Kim SH
Histol Histopathol; 2009 Mar; 24(3):309-16. PubMed ID: 19130400
[TBL] [Abstract][Full Text] [Related]
10. Sialosyl-Tn expression in normal and pathological conditions of human endometrium. An immunohistochemical study.
Semczuk A; Paszkowska A; Miturski R; Skomra D; Cybulski M; Jakowicki JA; Berbec H
Pathol Res Pract; 2002; 198(9):589-95. PubMed ID: 12440781
[TBL] [Abstract][Full Text] [Related]
11. ABH and related histo-blood group antigens in normal & malignant human endometrium in relation to genetic and hormonal factors.
Skovlund VR
APMIS Suppl; 1997; 69():1-33. PubMed ID: 9254838
[TBL] [Abstract][Full Text] [Related]
12. Oestrogen receptor in glands and stroma of normal and neoplastic human endometrium: a combined biochemical, immunohistochemical, and morphometric study.
Thornton JG; Wells M
J Clin Pathol; 1987 Dec; 40(12):1437-42. PubMed ID: 3323252
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of the c-myc oncogene product in normal, hyperplastic and carcinomatous endometrium.
Bai MK; Costopoulos JS; Christoforidou BP; Papadimitriou CS
Oncology; 1994; 51(4):314-9. PubMed ID: 8208512
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical evaluation of cathepsin D in normal, hyperplastic and malignant endometrium: correlation with hormone receptor status c-erbB-2, p53, Rb proteins and proliferation associated indices.
Ioachim E; Kitsiou E; Charalabopoulos K; Mitselou A; Zagorianakou N; Makrydimas G; Tzioras S; Salmas M
Int J Gynecol Cancer; 2003; 13(3):344-51. PubMed ID: 12801267
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric analysis of cell surface antigen recognized by monoclonal antibody (MSN-1) in normal, hyperplasia, and carcinoma of endometrial cells: its diagnostic value for endometrial carcinoma.
Kobayashi Y; Tsukazaki K; Ohta K; Mikami M; Kubushiro K; Nozawa S
Cytometry; 1997 Feb; 30(1):23-7. PubMed ID: 9056738
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of the tumour marker CA-125 in normal, hyperplastic and malignant endometrial tissue.
Mylonas I; Makovitzky J; Richter DU; Jeschke U; Briese V; Friese K
Anticancer Res; 2003; 23(2A):1075-80. PubMed ID: 12820350
[TBL] [Abstract][Full Text] [Related]
17. Cathepsin D expression in normal, hyperplastic and malignant endometrial tissue: an immunohistochemical analysis.
Mylonas I; Makovitzky J; Richter DU; Jeschke U; Briese V; Friese K
Acta Histochem; 2003; 105(3):245-52. PubMed ID: 13677618
[TBL] [Abstract][Full Text] [Related]
18. Metallothionein and RCAS1 expression in comparison to immunological cells activity in endometriosis, endometrial adenocarcinoma and endometrium according to menstrual cycle changes.
Wicherek L; Popiela TJ; Galazka K; Dutsch-Wicherek M; Opławski M; Basta A; Klimek M
Gynecol Oncol; 2005 Dec; 99(3):622-30. PubMed ID: 16112719
[TBL] [Abstract][Full Text] [Related]
19. Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal, hyperplastic, and neoplastic endometrium.
Afify AM; Craig S; Paulino AF; Stern R
Ann Diagn Pathol; 2005 Dec; 9(6):312-8. PubMed ID: 16308159
[TBL] [Abstract][Full Text] [Related]
20. Expression of the inhibin-alpha subunit in normal, hyperplastic and malignant endometrial tissue: an immunohistochemical analysis.
Mylonas I; Makovitzky J; Richter DU; Jeschke U; Briese V; Friese K
Gynecol Oncol; 2004 Apr; 93(1):92-7. PubMed ID: 15047219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
